Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class I · High risk Terminated Initiated Apr 20, 2023 (3 years ago)

G-Supress DX

Class I — High risk. Reasonable probability of serious harm or death.

Why it was recalled

Product mix-up: incorrect product was found inside the G-Supress DX product carton.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

G-Supress DX (Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl) Pediatric Drops Cough Suppressant Expectorant Nasal Decongestant, Cherry Flavor Sugar & Alcohol Free, packaged in a bottle Net Content: 30 mL (1 oz.) further packaged in a carton, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-655-01

Affected NDC 52083-0655-01

Compare with the code on your package — it is the most precise check available.

Drug: Alcohol

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
G-Supress DX
Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride
NDC 52083-0655
DEXTROMETHORPHAN HYDROBROMIDE 5 mg/mL; GUAIFENESIN 50 mg/mL; PHENYLEPHRINE HYDROCHLORIDE 2.5 mg/mL Syrup
Oral
Kramer Novis OTC
Recalling firm
Novis PR, LLC dba Kramer Novis
NDC code
52083-655-01
Origin
PR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0868-2023 · FDA notice

Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Alcohol recalls

See all

Other recalls by Novis PR, LLC dba Kramer Novis

All 2023 recalls
Class I · High risk

Pecgen DMX Cough Suppressant Expectorant

Labeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label incorrectly states children 6 to under 2 years of age, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or directed by physician. The label should state children 6 to under 12, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or as directed by physician. Additionally, the label does not advise consumers to consult a doctor for children under 2 years of age.

Terminated Labeling / mix-up Novis PR, Inc. NDC 52083-630-16 D-1395-2019